‌

US Patent 8911732 Anti-mesothelin antibodies and immunoconjugates

Patent 8911732 was granted and assigned to Genentech on December, 2014 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

Patent

Patent attributes

Current Assignee

Genentech

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

8911732

Date of Patent

December 16, 2014

Patent Application Number

13330414

Date Filed

December 19, 2011

Patent Citations Received

‌

US Patent 11851491 Compositions and methods for TCR reprogramming using fusion proteins

‌

US Patent 11965012 Compositions and methods for TCR reprogramming using fusion proteins

‌

US Patent 11884720 Antibody constructs for MSLN and CD3

‌

US Patent 12103976 Fc binding fragments comprising a CD137 antigen-binding site

‌

US Patent 11981745 Anti-mesothelin antigen-binding molecules and uses thereof

Patent Primary Examiner

‌

Brian J Gangle

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 8911732 Anti-mesothelin antibodies and immunoconjugates

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API